FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA: Preliminary Result...

di Nti, Akosua A., Serrano, Leona W., Sandhu, Harpal S., Uyhazi, Katherine E., Edelstein, Ilaina D., Zhou, Elaine J., Bowman, Scott, Song, Delu, Gangadhar, Tara C., Schuchter, Lynn M., Mitnick, Sheryl, Huang, Alexander, Nichols, Charles W., Amaravadi, Ravi K., Kim, Benjamin J., Aleman, Tomas S.
Pubblicato in Retina (2019)